Registration Frequencies

Fig 1) Patient numbers by biologic treatment at inclusion
Last update: | n= | updated weekly
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: | n= | updated weekly
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 935 10
Brodalumab 125 0
Certolizumab 26 0
Efalizumab 35 0
Etanercept 337 37
Golimumab 26 0
Guselkumab 185 0
Infliximab 99 1
Ixekizumab 212 0
Secukinumab 925 0
Tildrakizumab 15 0
Ustekinumab 634 0
Apremilast 349 0
Ciclosporin 355 0
Fumaderm 2510 0
Skilarence 664 0
Methotrexate 2371 0
other systemics 321 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: | n= | updated weekly
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: | n= | updated weekly
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: | n= | updated monthly
Fig. 5) Registered PsoBest centers